Glycogen storage disease type III presenting with secondary diabetes and managed with insulin: A case report

Cases Journal

Volumn 2, Issue 6, 2009, Pages

  Ismail, Heba ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; AMENORRHEA; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CONVULSION; CREATINE KINASE BLOOD LEVEL; DEHYDRATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG DOSE INCREASE; ENZYMATIC ASSAY; ENZYME DEFICIENCY; ESCHERICHIA COLI; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCOGEN STORAGE DISEASE TYPE 3; GROWTH RETARDATION; HEPATOMEGALY; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; LABORATORY TEST; LIVER BIOPSY; LIVER DYSFUNCTION; MEDICAL RECORD REVIEW; MYOPATHY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL EXAMINATION; URINE CULTURE;

EID: 77953453834     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.4076/1757-1627-2-6891     Document Type: Article

References (8)

1. th edition. Edited by John Fernandes, Jean-Marie Saudubray, Georges Van Den Berghe, John H. Walter. Springer; 2006:108-109.
2. Moe PJ, Waaler PE, Garatun-Tjeldstù O: Glycogen storage disease type III and diabetes mellitus. Acta Paediatr Scand 1972, 61:483-486.
3. Oki Y, Okubo M, Tanaka S, Nakanishi K, Kobayashi T, Murase T: Diabetes mellitus secondary to glycogen storage disease type III. Diabet Med 2000, 17:810-812.
4. Collins JR, Crofford OB: Glucose intolerance and insulin resistance in patients with liver disease. Arch Intern Med 1969, 124:142-148.
5. Conn HO, Schreiber W, Elkington SG: Cirrhosis and diabetes. II. Association of impaired glucose tolerance with portalsystemic shunting in Laennec's cirrhosis. Am J Dig Dis 1971, 16:227-239.
6. Masumoto T, Ishikawa M, Yamauchi Y, Hiasa Y, Yamamoto K, Iuchi H, Ohkubo K, Akbar SMF, Michitaka K, Horiike N, Onji M: Druginduced hepatitis with severe cholestasis due to voglibose. International Hepatology Communications 1996, 5:289-296.
7. Shuichi, Takushi A, Kouji H, Hirotaka M, Makoto O, Hiroomi M, Terukatsu A: Hepatic Necrosis with Cholestasis Induced by Long-term Voglibose Administration. Internal Medicine 2001, 40:484-488.
8. Goke B, Fuder H, Wieckhorst G, Theiss U, Stridde E, Littke T, Kleist P, Arnold R, Lücker PW: Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve. Digestion 1955, 56:493-501.